News | March 24, 2026
Japan okays new long-acting eye drug
It promises fewer injections for vision loss patients
It promises fewer injections for vision loss patients
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
The Phase 2 envisionGI study is testing deudomperidone, an experimental drug aimed at treating idiopathic gastroparesis
The framework introduces 15 consensus terms and definitions grouped across four core dimensions of skin health
This study demonstrates the power of real-time glucose information for people with Type 2 diabetes treated with basal insulin
The trial’s primary goal is to evaluate vipoglanstat’s effect on endometriosis-related pain during non-menstrual days
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
KEYTRUDA had previously met its primary endpoint of progression-free survival in all patients
The new lineup features everything from the Color Fixation and Hair Therapy ranges to the Balanced Cleansing Shampoo and Nourishment & Protection Conditioner
Subscribe To Our Newsletter & Stay Updated
